Norovirus Epidemiology and Genotype Circulation during the COVID-19 Pandemic in Brazil, 2019–2022
Pathogens · 2023
DOI: 10.3390/pathogens13010003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2023. Verfasst von Sylvia Kahwage Sarmento und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Comparative and Environmental Virology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21045-900, RJ, Brazil. Hauptthemen laut MEDLINE: Norovirus, COVID-19, Caliciviridae Infections, Genotype. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Brazilian National Council for Scientific and Technological Development (CNPq), FAPERJ—Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Ja…, CGLab, Brazilian Ministry of Health.
Abstract (Originalsprache)
Norovirus stands out as a leading cause of acute gastroenteritis (AGE) worldwide, affecting all age groups. In the present study, we investigated fecal samples from medically attended AGE patients received from nine Brazilian states, from 2019 to 2022, including the COVID-19 pandemic period. Norovirus GI and GII were detected and quantified using RT-qPCR, and norovirus-positive samples underwent genotyping through sequencing the ORF1/2 junction region. During the four-year period, norovirus prevalence was 37.2%, varying from 20.1% in 2020 to 55.4% in 2021. GII genotypes dominated, being detected in 92.9% of samples. GII-infected patients had significantly higher viral concentrations compared to GI-infected patients (median of 3.8 × 107 GC/g and 6.7 × 105 GC/g, respectively); and patients aged >12–24 months showed a higher median viral load (8 × 107 GC/g) compared to other age groups. Norovirus sequencing revealed 20 genotypes by phylogenetic analysis of RdRp and VP1 partial regions. GII.4 Sydney[P16] was the dominant genotype (57.3%), especially in 2019 and 2021, followed by GII.2[P16] (14.8%) and GII.6[P7] (6.3%). The intergenogroup recombinant genotype, GIX.1[GII.P15], was detected in five samples. Our study is the first to explore norovirus epidemiology and genotype distribution in Brazil during COVID-19, and contributes to understanding the epidemiological dynamics of norovirus and highlighting the importance of continuing to follow norovirus surveillance programs in Brazil.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Comparative and Environmental Virology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21045-900, RJ, Brazil.
ORCID-Profile: Juliana da Silva Ribeiro de Andrade, Fábio Correia Malta, Alexandre Madi Fialho, Mateus de Souza Mello, Fernanda Marcicano Burlandy, Tulio Machado Fumian
Förderung
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Brazilian National Council for Scientific and Technological Development (CNPq), FAPERJ—Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Ja…
- CGLab, Brazilian Ministry of Health
Zitieren
APA
Sarmento, S. K., de Andrade, J. D. S. R., Malta, F. C., Fialho, A. M., Mello, M. S., Burlandy, F. M., & Fumian, T. M. (2023). Norovirus Epidemiology and Genotype Circulation during the COVID-19 Pandemic in Brazil, 2019–2022. Pathogens. https://doi.org/10.3390/pathogens13010003
Vancouver
Sarmento SK, de Andrade JDSR, Malta FC, Fialho AM, Mello MS, Burlandy FM, et al. Norovirus Epidemiology and Genotype Circulation during the COVID-19 Pandemic in Brazil, 2019–2022. Pathogens. 2023. doi:10.3390/pathogens13010003
BibTeX
@article{Sarmento2023,
author = {Sarmento, Sylvia Kahwage and de Andrade, Juliana da Silva Ribeiro and Malta, Fábio Correia and Fialho, Alexandre Madi and Mello, Mateus de Souza and Burlandy, Fernanda Marcicano and Fumian, Tulio Machado},
title = {Norovirus Epidemiology and Genotype Circulation during the COVID-19 Pandemic in Brazil, 2019–2022},
journal = {Pathogens},
year = {2023},
doi = {10.3390/pathogens13010003}
}
EUVIMED